Biomedical

The University of California, Los Angeles dedicated the Edie & Lew Wasserman Building in October of 2014. Designed by Richard Meier and Partners Architects, the $115.6 million research and treatment facility provides space for the Stein Eye Institute, the Department of Neurosurgery, and the Institute of Urologic Oncology. Integrating patient care, medical research, and physician training, the six-story, 100,000-sf project will support the collaboration of multidisciplinary physician teams.

The four-story Jackson Laboratory for Genomic Medicine (JAX GM), containing both biological and computational lab space arranged around a central atrium, houses 160 biomedical researchers, technicians, and support staff from five different temporary spaces on the University of Connecticut Health Center campus. The number of occupants is expected to grow to 300 within three years, and the labs are flexible enough to accommodate the expected trend away from the wet bench toward more computational research.

Ohio State University Medical Center dedicated the $1 billion James Cancer Hospital and Solove Research Institute in Columbus in November of 2014. Designed for the delivery of personalized, genomics-based therapies, the 21-story tower features biomedical labs integrated into inpatient floors to provide true bench-to-bedside translational research and treatment. The hospital provides 14 technology-rich operating rooms, a 15-bed emergency department, and a radiation oncology center with seven vaults.

Gilead Sciences broke ground in October of 2014 on a $50 million laboratory building in Edmonton, Alberta. Designed by Manasc Isaac Architects, the 44,000-sf facility will accommodate 80 additional employees engaged in pharmaceutical research, development, and production. The construction manager for the project is Graham Group and completion is expected in spring of 2016.

Novo Nordisk began construction in October of 2014 on a $127 million biomedical research facility in Måløv, Denmark, to support the development of treatments for diabetes. Housing 350 employees, the three-story, 177,600-sf project will be built as two laboratory wings connected by a central structure housing offices and an auditorium. Occupancy is expected in early 2016.

Ground was broken on the USC Michelson Center for Convergent Bioscience in October of 2014. The 190,000-sf facility will provide the University of Southern California with collaborative labs and offices for up to 30 scientists and engineers engaged in translational research. Representing a partnership between the USC Dornsife College of Letters, Arts and Sciences and the USC Viterbi School of Engineering, the project will house the Center for Electron Microscopy and Analysis, a nanofabrication facility, and a microscopy imaging technology suite.

The Westmead Millennium Institute for Medical Research opened its $110 million laboratory and headquarters facility in October of 2014 in Sydney. Designed by BVN, the nine-story, 188,370-sf building provides flexible labs and core facilities for the development of advanced biomedical therapies. The translational research center will accommodate up to 400 researchers, clinicians, postgraduate students, and staff, and features a central atrium to promote interdisciplinary collaboration and interaction.

The University of Arizona broke ground in October of 2014 on the $136 million Biosciences Partnership Building. Located on the Phoenix Biomedical Campus, the 10-story, 245,000-sf facility was designed by CO Architects and Ayers Saint Gross to support collaborative biomedical research. Providing wet and dry labs as well as computational space, the transdisciplinary project is being built by DPR and Sundt Construction. Completion is expected in early 2017.

The University of Virginia School of Medicine dedicated the Ivy Foundation Translational Research Building in October of 2014. Located in the Fontaine Research Park in Charlottesville, the collaborative, interdisciplinary facility will house twelve scientific programs and a clinical research unit for the creation of advanced biomedical therapies. Construction of the project is funded in part by a $45 million donation from the Ivy Foundation.

The new four-story Cancer and Cardiovascular Research Building at the University of Minnesota consists of the 158,000-sf Cancer Research Building, a 96,000-sf addition to the Lillehei Heart Research Building, and a 34,000-sf vivarium used by the entire Biomedical Discovery District. The facility houses the University’s Department of Integrative Biology and Physiology, as well as two groups of investigators from Masonic Cancer Center: chemical biologists focusing on studying chemical carcinogens as a cause of cancer, and faculty focusing on novel therapeutic strategies to fight cancer.

The Jackson Laboratory opened the $135 million JAX Genomic Medicine facility in October of 2014 in Farmington, Conn. Located on 17 acres at the University of Connecticut Health Science Center, the four-story, 183,500-sf building features 17 wet labs and 17 dry labs arranged in flexible, collaborative clusters. The facility also provides core service labs, two large conference rooms, offices, a data center, and a 200-seat auditorium.

The Phase II addition to the John Edward Porter Neuroscience Research Center (PNRC) houses 419 occupants, including 45 principal investigators (PIs) from 10 separate NIH Institutes, along with 374 post-doctoral researchers. The PNRC is a state-of-the-art research facility that promotes world-class biomedical neuroscience research by enhancing interdisciplinary communication and collaboration as a means of facilitating innovation and creativity.

Central Michigan University began construction in September of 2014 on the $95 million Biosciences Building in Mount Pleasant. Designed by Stantec, the four-story, 169,000-sf facility will provide teaching labs, research labs, a BSL-3 suite, lecture halls, classrooms, faculty offices, an auditorium, an herbarium, an imaging center, and an aquatic research vivarium. Occupancy is expected in January of 2017. LEED Silver sustainable design certification will be sought for the project, which is is being built by Clark Construction.

Novartis is partnering with the University of Pennsylvania to create the Center for Advanced Cellular Therapeutics. Located on the Penn Medicine Campus in Philadelphia, the 30,000-sf facility will accommodate research on personalized cellular cancer therapies using chimeric antigen receptor technology (CAR). Supported by $20 million in funding from Novartis, the project will be built on top of the Jordan Medical Education Center and South Pavilion Extension, which is currently under construction. Completion is expected in 2016.

The Wistar Institute completed the $100 million Robert and Penny Fox Tower in Philadelphia in September of 2014. Designed by Ballinger to promote interaction and collaboration, the seven-story, 89,000-gsf facility provides advanced biomedical research space for the study of cancer, genetics, and vaccine development. Located on the University of Pennsylvania campus, the project represents an expansion of Wistar's existing facilities and increased the number of labs from 30 to 46, as well as delivering upgraded building infrastructure systems.